Live Events

Shaping the Management of Parkinson's Disease

1.23.21 and 1.24.21
Shaping the Management of Parkinson's Disease CME

 8th Annual Shaping the Management of Parkinson's Disease:

Debating Current Controversies and Discussing Recent Advances

 

January 23, 2021, 8:30 am - 4:00 pm EST

January 24, 2021, 8:30 am - 1:30 pm EST

 


Description

Innovations and advances in the field of PD — including evaluation, treatment, and prevention — continue to occur at a rapid pace, challenging both specialists and generalists to stay abreast of the changes, creating gaps in knowledge, competence, and practice among health care providers. In many cases, the data are not clear regarding the clinical implications. In turn, this creates a pressing need for educational activities focused on providing updates and critical analyses of both the pros and cons of the most recent advances in the care of patients with PD.

Directors & Faculty

Directors

Hubert Fernandez, MD, FAAN
Cleveland Clinic

Michael Schwarzchild, MD, PhD
Massachusetts General Hospital


Additional Faculty

Roy Alcalay, MD, MS
Columbia University

Helen Bronte-Stewart, MD, MS
Stanford University

Susan Fox, MRCP, PhD
University of Toronto

Joohi Jimenez-Shahed, MD
Icahn School of Medicine at Mount Sinai

Peter Lewitt, MD
Henry Ford Hospital

Zoltan Mari, MD
Cleveland Clinic

Aristide Merola, MD, PhD
The Ohio State University

Tiago Mestre, MD, MSc
University of Ottawa

Martha Nance, MD
Struthers Parkinson's Center

William Ondo, MD
Methodist Hospital Houston

Fernando Pagan, MD
Gerogetown University

Gregory Pontone, MD, MHS
The Johns Hopkins Hospital

Liana Rosenthal, MD, PhD
The Johns Hopkins Hospital

Marie Saint-Hilaire, MD, MRCP(C), FAAN
Boston University

Andrew Siderowf, MD, MSCE
University of Pennsylvania

Tanya Simuni, MD
Northwestern University

Allison Willis, MD, MS
University of Pennsylvania

Anne-Marie Wills, MD, MPH
Massachusetts General Hospital

Michele York, PhD, ABPP-CN
Baylor College of Medicine

Agenda

Objectives

After completing this activity, the participant will be able to do the following:

  • List the most recent insights from studies investigating the role of genetic targets in disease- modifying therapies for Parkinson disease.
  • Discuss how COVID-19 has promoted telemedicine for follow-up care of patients with Parkinson disease as well as its impact on clinical trial design.
  • Summarize the evidence supporting the efficacy of behavioral and nonmotor therapies for Parkinson disease.
  • Critically assess the outcomes and issues when comparing closed-loop technology against directional leads for deep brain stimulation.
  • Describe the available neuropsychological tests for detecting mild cognitive impairment in Parkinson disease and discuss the best timing of their use.
  • List the options for short-acting rescue therapies in Parkinson disease and their potential use as on-demand therapy.
  • Discuss the accuracy of the scale for measuring motor fluctuations in Parkinson disease in relation to its use as an outcome measure in symptomatic trials.

Disclosures and Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Cleveland Clinic Foundation Center for Continuing Education and Parkinson Study Group. The Cleveland Clinic Foundation Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.

 

The Cleveland Clinic Foundation Center for Continuing Education designates this internet live activity for a maximum of 10 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME.